TRIALSITEIQ PUBLIC FEASIBILITY SCORECARD · GRADE D-

NCT06982820: Self Neuro-modulation Therapy for Major Depressive Disorder (MDD) With Anhedonia

Sponsor: GrayMatters Health Ltd. · Phase: PHASE2 · Area: CARDIOLOGY_METABOLIC · Target Enrollment: 170 pts

Competing Trials Overlap

4 Active Trials

Excess Burn Exposure

$10,624,000

Rescue Site Savings

+$7,005,200

Unlock Full NCT06982820 Backup Super-Site Packet ($49 One-Time Pass)

Download the complete list of top-decile low-cannibalization clinical sites, verified Principal Investigator (PI) direct emails/phones, and protocol optimization benchmarks.

Download $49 NCT06982820 Rescue Dossier →